KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.

Main|Search|PHGKB

From From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.  
  Sadlecki Pawel et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Oct 39(10) 1010428317733984
• Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer.  
  Borad Mitesh J et al. Mayo Clinic proceedings 2017 Oct 92(10) 1583-1591
• Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research.  
  Mardamshina Mariya et al. The American journal of pathology 2017 Oct 187(10) 2175-2184
• Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.  
  Heong Valerie et al. International journal of cancer 2017 Oct
• Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand.  
  Filoche Sara et al. BMC pregnancy and childbirth 2017 Oct 17(1) 344

more